Aura Biosciences, Inc. Common Stock (AURA)
Business numbers score is on the low side, with score for how it compares with the broader market is below the middle.
AURA scores higher than 51% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Aura Biosciences, Inc. Common Stock (AURA) scores 41 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 1.06× 30-day average
- 52-week range
- 4.73 – 9.54
- Market cap
- $667.86M
- Earnings date
- 5 Nov 2026
- Volume
- 962,557
- Avg. volume (30d)
- 904,647
- Open
- 6.48
- Previous close
- 6.50
- Day's range (regular session)
- 6.46 – 6.70
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.40
- P/E (TTM)
- —
- EPS (TTM)
- -1.76
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for AURA
- 5 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for AURA. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about AURA right now
Aura Biosciences, Inc. Common Stock (AURA) currently scores 41/100 on the Market Census six-factor composite, at the Average score level. AURA is +0.54% on the day and +7.39% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in AURA's data roughly balance out right now. AURA's strongest factor is price trend at 56/100 — a fairly good read on which way the price has been going. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See AURA in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent AURA news
Latest headlines that name Aura Biosciences, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Aura Biosciences, Inc. (AURA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeekingAlpha
- Is Aura Investments (TASE:AURA) Fully Valued As Mixed Earnings And A New Dividend Stir Interest?Yahoo
- Aura Biosciences to Participate in Upcoming Investor ConferenceYahoo
- Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Yahoo
- Aura Biosciences: Ocular Oncology Firm Under New Management Has Shot At ApprovalSeekingAlpha
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to AURA’s 41, all within 1 point.
Sorted by closeness to AURA’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.